PLAZA MEDICAL LIMITEDActive

Company number 11277371Private limited companyIncorporated 2018

Key figures

£1,057,207+15.8%
Net assets 2024/25
+28.6%
Average annual growth 2019/20–2024/25
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25

Like most small UK companies, PLAZA MEDICAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Profit for the year166,175————
Cash at bank and in hand23,63615,29239,63739,43335,722
Total assets23,64615,30239,64739,443186,126
Total liabilities642,420454,282298,798144,840124,316
Net assets / total equity467,115624,286781,492912,6231,057,207
Average number of employees00050

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PLAZA MEDICAL LIMITED

Company

PLAZA MEDICAL LIMITED is a private limited company registered with Companies House under company number 11277371. It was incorporated on 27 Mar 2018. Its status is active. The registered office is in Widnes (WA8). Its nature of business (SIC 2007) is activities of other holding companies n.e.c. (64209).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £1,057,207, up 15.8% on the previous year. Cash at bank and in hand was £35,722. Total assets were £186,126 and total liabilities £124,316. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

The company has 5 current directors. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 9 Apr 2027.